Featured Stories

Biocorridor Update

The Wall Street Journal recently reported major pharmaceutical companies have made deals valued at $20 billion dollars. Much of that involves GlaxoSmithKline (GSK), whose North American vaccine operation will be based in the Bryan/College Station [Read More…]